Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying how well temozolomide works in treating patients
with high-risk relapsed or refractory neuroblastoma.